PARAMUS, N.J., Dec. 5, 2023 /PRNewswire/ -- Octapharma USA announced the expansion of the U.S. Food and Drug Administration (FDA) approval for wilate ®, von Willebrand Factor/Coagulation Factor VIII ...
Thromboembolism prophylaxis with aspirin is as effective as low-molecular-weight heparin in preventing mortality at 90 days in orthopedic trauma patients with fractures of an extremity, pelvis, or hip ...
How do the 2007 IE prevention guidelines differ from the prior (1997 [11]) iteration? There are three major differences in the current version. The "highest-risk" group for whom antibiotic prophylaxis ...
We conducted a retrospective cohort study of patients discharged between January 1, 2004 and June 30, 2005 from 333 acute care facilities in the United States that participated in Premier's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback